Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 10.63 is 79% above its 5-year average of 5.93, near the high end of its 5-year range (3.78–10.63).
As of the fiscal period ended Tuesday, June 30, 2026. 55.99% above its 12-month average of 6.81.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 10.63.
QUICK RATIO (ACID-TEST)
10.63
QUICK RATIO (ACID-TEST) AVG TTM
6.81
QUICK RATIO (ACID-TEST) AVG 3Y
5.60
QUICK RATIO (ACID-TEST) AVG 5Y
5.93
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+55.99%
CURRENT VS 3Y AVG
+89.61%
CURRENT VS 5Y AVG
+79.15%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
+216.75%
vs the sector median at left
Absci Corporation
Market Cap
$1.74B
Quick Ratio (Acid-Test)
10.63
TTM Avg
6.81
3Y Avg
5.60
5Y Avg
5.93
Market Cap
$1.74B
Quick Ratio (Acid-Test)
1.02
TTM Avg
1.38
3Y Avg
1.55
5Y Avg
2.14
Market Cap
$1.74B
Quick Ratio (Acid-Test)
1.70
TTM Avg
1.79
3Y Avg
1.95
5Y Avg
2.14
Market Cap
$1.73B
Quick Ratio (Acid-Test)
6.65
TTM Avg
5.42
3Y Avg
7.28
5Y Avg
7.47
Market Cap
$1.75B
Quick Ratio (Acid-Test)
1.78
TTM Avg
1.68
3Y Avg
1.66
5Y Avg
1.61
Market Cap
$1.71B
Quick Ratio (Acid-Test)
5.08
TTM Avg
6.50
3Y Avg
5.46
5Y Avg
6.20
Market Cap
$1.77B
Quick Ratio (Acid-Test)
8.30
TTM Avg
3.78
3Y Avg
3.78
5Y Avg
3.78
Market Cap
$1.71B
Quick Ratio (Acid-Test)
1.07
TTM Avg
0.89
3Y Avg
0.95
5Y Avg
0.97
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Absci Corporation (ABSI) | $1.74B | 10.63 | 6.81 | 5.60 | 5.93 |
| Xeris Biopharma Holdings, Inc. (XERS)vs › | $1.74B | 1.02 | 1.38 | 1.55 | 2.14 |
| Novocure Ltd (NVCR)vs › | $1.74B | 2.70 | 2.06 | 4.13 | 5.41 |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.74B | 1.70 | 1.79 | 1.95 | 2.14 |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.73B | 6.65 | 5.42 | 7.28 | 7.47 |
| Surgery Partners, Inc. (SGRY)vs › | $1.75B | 1.78 | 1.68 | 1.66 | 1.61 |
| Personalis, Inc. (PSNL)vs › | $1.71B | 5.08 | 6.50 | 5.46 | 6.20 |
| Generate Biomedicines, Inc. (GENB)vs › | $1.77B | 8.30 | 3.78 | 3.78 | 3.78 |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.71B | 1.07 | 0.89 | 0.95 | 0.97 |
| Zenas BioPharma, Inc. (ZBIO)vs › | $1.70B | 9.93 | 5.91 | 4.26 | 4.26 |
Quick Ratio
10.63
Excludes inventory
Current Ratio
10.63
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 10.63 |
| 2026-03-31 | 6.59 |
| 2025-12-31 | 6.57 |
| 2025-09-30 | 5.89 |
| 2025-06-30 | 4.39 |
| 2025-03-31 | 5.72 |
| 2024-12-31 | 4.67 |
| 2024-09-30 | 5.63 |
| 2024-06-30 | 6.49 |
| 2024-03-31 | 7.19 |
| 2023-12-31 | 4.08 |
| 2023-09-30 | 4.24 |
| 2023-06-30 | 5.81 |
| 2023-03-31 | 6.08 |
| 2022-12-31 | 5.68 |
| 2022-09-30 | 6.71 |
| 2022-06-30 | 7.19 |
| 2022-03-31 | 6.11 |
| 2021-12-31 | 7.75 |
| 2021-09-30 | 9.94 |
| 2021-06-30 | 3.78 |
| 2021-03-31 | 10.66 |
| 2020-12-31 | 7.25 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
